Ozempic rules tightened – half of all diabetics may have to switch medication

Up to half of all those with type 2 diabetes in Denmark may have to change their medication, as the Danish Medicines Agency announces it will tighten the rules for subsidies on GLP-1 drugs.

Photo: Novo Nordisk

Up to half of all those with type 2 diabetes in Denmark may have to change their medication, as the Danish Medicines Agency announces it will tighten the rules for subsidies on certain drugs.The new rules apply to GLP-1 analogue medicines, which primarily consist of Novo Nordisk’s Ozempic. A significant number of new diabetes patients in […]


Gain unlimited access to all of The Copenhagen Post

Our independent reporting can only be published with support from our readers.

Monthly subscription

119

DKK/month.

(Billed once a month)

Give us a try

6 month subscription

99

DKK/month.

(Billed twice a year)

Save 120 DKK

Yearly subscription

79

DKK/month.

(Billed once a year)

Save 480 DKK

Save with a company subscription?




Connect Club is your gateway to a vibrant programme of events and an international community in Denmark.